glo1 tirzepatide Weight Loss Injections Compound Tirzepatide
Description
Much hyped online, FDA-approved diabetes wonder drugs, now touted for treating obesity
Heard the whispers, haven't you
.webp)
Pharmaceutical giantEli Lilly announced plans Tuesday to invest []
Several studies suggest that 15%-40% of IBD patients are obese
But despite widespread use of these drugs by perimenopausal women, research has largely ignored the unique risks and potential opportunities for optimizing health that GLP-1s may pose for this population.
Understanding recent updates to the risks associated with semaglutide
